In this study, we demonstrated that the novel, modified peptide MHP1-AcN, which was structurally designed from RANKL and modified with N-terminal acetylation and C-terminal amidation to improve its stability and effectiveness, significantly prevented the development of IMQ-induced psoriasis in mice. This evidence concerns the gene TNFSF11 and psoriasis.